Abstract: Co-administration of a lysostaphin or other anti-staphylococcal agent which cleaves cross-links of peptidoglycans of staphylococci cell walls such as lysostaphin and an antibiotic effective against staphylococci due to antibiotic activity mediated by cell-wall activity is effective against staphylococcal infection, even staphylococci that may be resistant to one or other of lysostaphin or the cell-wall active antibiotic. Co-administration simultaneously suppresses the generation of antibiotic-resistant mutant strains. Effective cell-wall active antibiotics include &bgr;-lactams and glycopeptides.
Type:
Grant
Filed:
March 5, 1999
Date of Patent:
May 27, 2003
Assignee:
Ambi, Inc.
Inventors:
Michael Climo, Ellen Murphy, Gordon Archer
Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
Type:
Grant
Filed:
May 4, 2001
Date of Patent:
October 29, 2002
Assignee:
Ambi, Inc.
Inventors:
Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in the form of enteric-coated tablets, capsules or microbeads, optionally in combination with nicotinic acid, picolinic acid or both nicotinic acid and picolinic acid. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
Type:
Grant
Filed:
October 26, 2000
Date of Patent:
June 26, 2001
Assignee:
AMBI, Inc.
Inventors:
Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
Abstract: Compositions comprising chromic tripicolinate or chromic polynicotinate in combination with at least one of a cyclooxygenase inhibitor, an acid, a mucolytic and a salicin-containing herb. The compositions are useful for supplementing dietary chromium, lowering blood glucose levels, lowering serum lipid levels and increasing lean body mass.
Type:
Grant
Filed:
January 10, 2000
Date of Patent:
June 26, 2001
Assignee:
Ambi, Inc.
Inventors:
Jon de la Harpe, Fredric D. Price, Lawrence W. Chakrin, James R. Komorowski, Lauren K. Skluth
Abstract: The invention relates to methods and compositions for masking the taste of minerals in ingestible products. In particular, tannic acid glycyrrhizin and acesulfame potassium are added to compostions comprising minerals such as potassium, calcium, magnesium, iron, copper, chromium, zinc and mixtures in order to reduce or eliminate the unpleasant taste or aftertase associated with these minerals.